Trial Profile
A Double-Blind, Multicenter, Placebo Controlled Study of Aldosterone Blockade (Eplerenone) in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia in the Absence of Significant Epicardial Coronary Artery Disease.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Eplerenone (Primary) ; ACE inhibitors; Angiotensin receptor antagonists
- Indications Ischaemic heart disorders
- Focus Pharmacodynamics
- Acronyms EWISE
- 13 Dec 2011 Actual end date changed from Feb 2009 to Dec 2011 as reported by ClinicalTrials.gov.
- 05 Oct 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 26 Aug 2010 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.